In its 10th year, the Lancet Countdown’s findings are stark: real progress in clean energy, adaptation, and evidence is being ...
The treatment landscape of EGFR-mutated non-small-cell lung cancer harbouring exon 19 deletion or L858R mutations has ...
Sickle cell disease is the most common haemoglobinopathy, affecting more than 7 million people worldwide.1 Despite ...
For 70 years, corticosteroids have been the default treatment for sarcoidosis.1 Although the field has repeatedly tried to ...
Radionuclide theranostics is transforming oncology by enabling more personalised treatment based on tumour biology. The ...
It was a 2015 Editorial in The Lancet Oncology discussing cancer in the transgender community, that set Alison Berner (Queen ...
Joanne Tinker remembers searching online for what a mastectomy would look like, convinced she was about to be mutilated. She ...
Latvia has one of the world's highest rates of alcohol consumption but recent policy changes are starting to lessen direct harms to health. Ed Holt reports.
Africa’s digital health revolution, marked by a rapid increase in the number of technologies and providers of electronic health records, mobile health applications, disease surveillance platforms, and ...
The introduction of thalidomide and its derivatives—lenalidomide, followed by pomalidomide—has improved the therapeutic ...
Every year, pivotal clinical trials are reported, showing major advances in cancer treatment. At the American Society of ...
Cancer experts fear a rise in cancer cases in Russia if a draft 2027 budget proposing a sharp cut of more than 90% in federal cancer funding is pushed through parliament.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results